Grant: Health System Impact Fellowships - Doctoral Western Canada 1-year
University of British Columbia
$35,000.00
Building system readiness for pharmacogenomic and companion diagnostic testing in British Columbia
FY 2022-23
Summary
Precision medicine is a ground-breaking approach that takes into account the differences in an individual's genetic profile to help tailor their medical treatment. In particular, pharmacogenomic and companion diagnostic testing have shown promise in improving patient outcomes and reducing healthcare system wastage and costs by helping identify medications that are more likely to be effective and/or reduce negative side effects based on the individual's genetic profile. In addition to critically assessing the potential health and health system efficiency benefits by the adoption of these tests into routine clinical care in British Columbia (BC), it is also essential to assess the readiness of BC's healthcare system for their implementation. This includes gaining a better understanding of existing infrastructures and resources that may be able to be leveraged and the potential gaps that would need to be addressed as part of implementation planning to ensure successful and sustainable implementation. The main goal of this proposed work will be to assess the readiness of the province of BC to implement pharmacogenomic and companion diagnostic testing into routine clinical care and provide recommendations towards system change that will be required to facilitate implementation. The objectives of this project will be to assess the current evidence (on effectiveness and cost-effectiveness) for pharmacogenomic and companion diagnostic testing within a Canadian context, identify and define criteria for judging system readiness, analyze BC's readiness for implementation in relation to the identified criteria, and lastly, to develop a white paper that highlights key recommendations for next steps in moving forward implementation.
Department
Program
Health System Impact Fellowships - Doctoral Western Canada 1-year
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
484603
Name
Waheed Zeina
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Fellowship : Health System Impact Fellowship Doctoral
Projecttitle
Building system readiness for pharmacogenomic and companion diagnostic testing in British Columbia
Programtype2
Fellowship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$35,000
Cihrequipment2
$0
Programname2
Health System Impact Fellowships - Doctoral Western Canada 1-year
Keyworddelim
Health Services Research
Abstract
Precision medicine is a ground-breaking approach that takes into account the differences in an individual's genetic profile to help tailor their medical treatment. In particular, pharmacogenomic and companion diagnostic testing have shown promise in improving patient outcomes and reducing healthcare system wastage and costs by helping identify medications that are more likely to be effective and/or reduce negative side effects based on the individual's genetic profile. In addition to critically assessing the potential health and health system efficiency benefits by the adoption of these tests into routine clinical care in British Columbia (BC), it is also essential to assess the readiness of BC's healthcare system for their implementation. This includes gaining a better understanding of existing infrastructures and resources that may be able to be leveraged and the potential gaps that would need to be addressed as part of implementation planning to ensure successful and sustainable implementation. The main goal of this proposed work will be to assess the readiness of the province of BC to implement pharmacogenomic and companion diagnostic testing into routine clinical care and provide recommendations towards system change that will be required to facilitate implementation. The objectives of this project will be to assess the current evidence (on effectiveness and cost-effectiveness) for pharmacogenomic and companion diagnostic testing within a Canadian context, identify and define criteria for judging system readiness, analyze BC's readiness for implementation in relation to the identified criteria, and lastly, to develop a white paper that highlights key recommendations for next steps in moving forward implementation.
Competitiondate
202303
Approvedterm2
1 yr 0 mth
Pinamesdelim
Waheed, Zeina
Approvedterm
1 an 0 mois
Cihrcontribution2
IHSPR~ $35,000~ $0~